Offer - Urjas Oil for just ₹ 1
Kaprolam 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Kaprolam 0.25 Mg Tablet is used -
Severe
Moderate
Mild
Is the use of Kaprolam 0.25 Mg Tablet safe for pregnant women?
Kaprolam can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Kaprolam 0.25 Mg Tablet safe during breastfeeding?
Taking Kaprolam may lead to serious side effects if you are breastfeeding. Kaprolam should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Kaprolam 0.25 Mg Tablet on the Kidneys?
Kaprolam rarely harms the kidneys.
What is the effect of Kaprolam 0.25 Mg Tablet on the Liver?
There may be severe side effects of Kaprolam on your liver. Do not take it unless a doctor says so.
What is the effect of Kaprolam 0.25 Mg Tablet on the Heart?
Kaprolam is rarely harmful for the heart.
Kaprolam 0.25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Kaprolam 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Kaprolam 0.25 Mg Tablet habit forming or addictive?
Kaprolam 0.25 Mg Tablet can be addictive. You should not take it without medical advice.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Kaprolam 0.25 Mg Tablet. So it is best to avoid driving.
Is it safe?
Kaprolam 0.25 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, Kaprolam 0.25 Mg Tablet is useful in treating mental disorders.
Interaction between Food and Kaprolam 0.25 Mg Tablet
Some foods when eaten with Kaprolam 0.25 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Kaprolam 0.25 Mg Tablet
Side effects of drinking alcohol and taking Kaprolam 0.25 Mg Tablet at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
Kaprolam is not the exact drug for the treatment of Insomnia. However, since Insomia patients also suffer from anxiety during the night this medicine can be taken to relax the mind and eventually induce sleep. Do not take it without consulting a physician.
Stopping or discontinuing Kaprolam on your own can cause withdrawal symptoms (seizures, difficulty in sleep, headache, nervousness, and depression). However, if you decide to stop/discontinue it, then stop it slowly, do not stop suddenly. However, please do not hesitate to discuss with your doctor if you are experiencing any withdrawal symptoms after stopping/discounting it on your own.
Yes, Kaprolam can be taken with Tylenol. No clinical significance interactions have been reported between them. However, if you experience any undesirable effects after consuming these two medicines at the same do not hesitate to inform the doctor.
No, Kaprolam cannot be taken with an opioid drug. It can cause life-threatening side effects such as sedation, respiratory problems, depression, and in rare consequences can lead to coma as well if these two combinations are mixed together.
Kaprolam is a prescription drug so do not take it without consulting doctor. It can be harmful for the people to take this medicine without a doctor's advice.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131
